THERIVA BIOLOGICS INC (TOVX) Stock Balance Sheet
NYSEARCA:TOVX - US87164U5083 - Common Stock
0.4192 USD
0 (-0.1%)
0.4199 USD
+0 (+0.17%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 12.12M | 11.61M | 23.18M | 41.79M | 67.33M | |||
| Receivables | 1.88M | 3.32M | 1.94M | 230.00K | 0.00 | |||
| Other Current Assets | 744.00K | 1.35M | 2.29M | 3.50M | 1.53M | |||
| Total Current Assets | 14.74M | 16.28M | 27.40M | 45.52M | 68.86M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.33M | 1.54M | 21.94M | 20.69M | 1.48M | |||
| Goodwill | N/A | 0.00 | 5.70M | 5.53M | N/A | |||
| Intangibles | 19.62M | 17.36M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 128.00K | 171.00K | 180.00K | 120.00K | 20.00K | |||
| Total Non-Current Assets | 21.09M | 19.07M | 27.82M | 26.34M | 1.51M | |||
| TOTAL ASSETS | 35.83M | 35.35M | 55.22M | 71.86M | 70.37M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 56.00K | 61.00K | 63.00K | 60.00K | N/A | |||
| Accrued Expenses | 4.40M | 5.05M | 5.00M | 3.12M | 3.03M | |||
| Accounts Payable | 607.00K | 859.00K | 770.00K | 920.00K | 520.00K | |||
| Other Current Liabilities | 7.33M | 1.61M | 906.00K | 2.97M | N/A | |||
| Total Current Liabilities | 12.39M | 7.58M | 6.74M | 7.06M | 3.55M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.64M | 92.00K | 162.00K | 220.00K | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 1.62M | N/A | |||
| Other Non-Current Liabilities | 11.17M | 8.61M | 8.62M | 8.40M | 1.40M | |||
| Total Non-Current Liabilities | 12.81M | 8.70M | 8.78M | 10.24M | 1.41M | |||
| TOTAL LIABILITIES | 25.21M | 16.29M | 15.52M | 17.30M | 4.96M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -352.35M | -334.97M | -309.32M | -290.97M | -271.28M | |||
| Additional Paid In Capital | 362.46M | 355.50M | 346.52M | 343.75M | 336.56M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 8.00K | 3.00K | 2.75M | 2.75M | 130.00K | |||
| Treasury Stock | -288.00K | -288.00K | -288.00K | -290.00K | N/A | |||
| Other Shareholders' Equity | 793.00K | -1.18M | 32.00K | -680.00K | N/A | |||
| Shares Outstanding | 9.06M | 2.78M | 17.15M | 15.12M | 13.20M | |||
| Tangible Book Value per Share | -0.99 | 0.61 | 1.82 | 3.06 | 4.96 | |||
| Total Shareholders' Equity | 10.62M | 19.07M | 39.70M | 54.56M | 65.41M | |||
| TOTAL LIABILITIES AND EQUITY | 35.83M | 35.35M | 55.22M | 71.86M | 70.37M | |||
| Statistics | ||||||||
| Debt/Equity | 0.15 | 0.00 | 0.00 | 0.00 | N/A | |||
| Current Ratio | 1.19 | 2.15 | 4.07 | 6.45 | 19.40 | |||
| Return On Assets (ROA) | -82.49% | -72.56% | -33.23% | -27.87% | -32.95% | |||
| Return On Equity (ROE) | -278.22% | -134.54% | -46.22% | -36.71% | -35.45% | |||
All data in USD , ROIC based on taxRate of 0.21